Explore more publications!

Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

Press releases published on February 3, 2026

New Study Identifies How Intensive Care Units Prevent Patient Harm Before It Occurs
Allsup Helps Workers Navigate Medicare Options Amid Rising Health Plan Costs
Cynet Named a Strong Performer in 2026 Gartner Peer Insights™ “Voice of the Customer” for Endpoint Protection Platforms
Carrington College and San Joaquin Valley College in Visalia to Host Complimentary Oral Health Screening and Sealant Clinic
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026
AdhereHealth Announces Appointment of CEO Kempton Presley and President & COO Patrick McNulty as Members of the Board of Directors
HFMA’s Vitalic Health to gather more than 50 payers, providers and tech leaders to address rising claim denials
Department of Education Proposal Still Excludes Nursing from “Professional Degree” Definition
Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
SRx Health Solutions Significantly Reduces Short Position of Cryptocurrency Portfolio Amidst Current Market Volatility
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
John Snow Labs Earns Pacific AI Governance Certification, Raising the Bar for Responsible AI in Healthcare
Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion
Clever Care Health Plan Increases Enrollment by Nearly 50 Percent in 2026 Medicare Annual Enrollment Period
Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Appointed to the Florida Board of Pharmacy by Governor Ron DeSantis
MedRisk Acquires Horizon Casualty Services
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions